[1] Catalano, P., Urken, M.L., Alvarez, M., et al. (1992) New approach to the management of airway obstruction in “High Risk” neonates. Archives of Otolaryngology—Head and Neck Surgery, 118, 306-309. http://dx.doi.org/10.1001/archotol.1992.01880030094019
[2] Bouchard, S., Johnson, M., Flake, A., et al. (2002) The EXIT procedure: Experience and Outcome in 31 cases. Journal of Pediatric Surgery, 3, 418-426. http://dx.doi.org/10.1053/jpsu.2002.30839
[3] Hirose, S., Farmer, D., Lee, H., Nobuhara, K.K. and Harrison, M.R. (2009) The ex utero intrapartum treatment procedure: Looking back at the EXIT. Journal of Pediatric Surgery, 39, 375-380. http://dx.doi.org/10.1016/j.jpedsurg.2003.11.011
[4] Hill, D. (2008) The use of remifentanil in obstetrics. Anesthesiology Clinics, 26, 169-182.
[5] Clark, K., Viscomi, C., Lowell, J. and Chien, E.K. (2004) Nitroglycerin for relaxation to establish a fetal airway (EXIT procedure). Obstetrics & Gynecology, 103, 1113-1115. http://dx.doi.org/10.1097/01. AOG.0000125158.61232.b3
[6] Egan, T.D. (2000) Pharmacokinetics and pharmacodynamics of remifentanil: An update in the year 2000. Current Opinion in Anaesthesiology, 13, 449-455. http://dx.doi.org/10.1097/00001503-200008000-00009
[7] Kan, R.E., Hughes, S.C., Rosen, M.A., Kessin, C., Preston, P.G. and Lobo, E.P. (1998) Intravenous remifentanil: Placental transfer, maternal and neonatal effects. Anesthesiology, 88, 1467-1474. http://dx.doi.org/10.1097/00000542-199806000-00008